转录因子Islet-1调控糖尿病诱导的内层血视网膜屏障破坏
该研究整合糖尿病视网膜病变患者临床样本、糖尿病小鼠模型及高糖暴露人视网膜微血管内皮细胞的体外实验,发现Islet-1表达升高与糖尿病视网膜病变进展及内层血视网膜屏障破坏相关。机制上,Islet-1上调导致血管内皮生长因子A表达增加,并降低视网膜血管内皮细胞中紧密连接蛋白Occludin和闭锁小带蛋白-1的水平。作者认为Islet-1是糖尿病视网膜病变中内层血视网膜屏障破坏的关键调控因子,靶向Islet-1过表达可能成为减轻内层血视网膜屏障功能障碍的新型治疗策略。
要点
- Islet-1表达升高与糖尿病视网膜病变进展及内层血视网膜屏障破坏相关。
- Islet-1上调增加血管内皮生长因子A表达并降低Occludin和闭锁小带蛋白-1水平。
- 作者认为靶向Islet-1过表达可能成为减轻内层血视网膜屏障功能障碍的新型治疗策略。
核心结论
- Islet-1是糖尿病视网膜病变中内层血视网膜屏障破坏的关键调控因子。
- 作者认为靶向Islet-1过表达可能代表一种减轻内层血视网膜屏障功能障碍及其相关视网膜病变的新型治疗策略。
研究设计与样本
- 研究整合糖尿病视网膜病变患者临床样本、糖尿病小鼠模型体内研究及高糖暴露人视网膜微血管内皮细胞体外实验。
- 采用免疫荧光染色、蛋白质印迹和定量实时聚合酶链反应检测Islet-1在糖尿病患者和实验糖尿病模型中的表达谱。
- 通过调控Islet-1表达评估其对糖尿病条件下内层血视网膜屏障完整性的影响,并探索参与内层血视网膜屏障破坏的分子通路。
主要发现
- Islet-1表达升高与糖尿病视网膜病变进展及内层血视网膜屏障破坏相关。
- Islet-1上调导致视网膜血管内皮细胞中血管内皮生长因子A表达增加。
- Islet-1上调导致视网膜血管内皮细胞中紧密连接蛋白Occludin和闭锁小带蛋白-1水平降低。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The transcription factor Islet-1 (Insulin gene enhancer protein Isl-1) has been implicated in diabetic retinal neovascularization, but its role in inner blood-retinal barrier (iBRB) dysfunction in diabetic retinopathy remains unclear. This study aimed to elucidate the mechanisms by which Islet-1 drives iBRB disruption under diabetic conditions by integrating analyses of clinical samples from patients with diabetic retinopathy, in vivo studies in diabetic mouse models, and in vitro experiments using hyperglycemia-exposed human retinal microvascular endothelial cells. METHODS: The expression profile of Islet-1 in diabetic patients and experimental diabetic models were investigated by immunofluorescence staining, Western blot (WB) and quantitative real-time polymerase chain reaction (qRT-PCR). Through the modulation of Islet-1 expression, we evaluated its impact on iBRB integrity under diabetic conditions and explored the molecular pathways involved in iBRB disruption. RESULTS: Our findings demonstrated that elevated Islet-1 expression correlates with the progression of diabetic retinopathy and the breakdown of the iBRB. Mechanistically, Islet-1 upregulation led to increased vascular endothelial growth factor A (VEGFA) expression and decreased levels of key tight junction proteins Occludin and Zonula occludens-1 (ZO-1) in retinal vascular endothelial cells. CONCLUSIONS: Our results establish Islet-1 as a critical regulator of iBRB disruption in diabetic retinopathy and suggest that targeting Islet-1 overexpression may represent a novel therapeutic approach to mitigate iBRB dysfunction and its associated retinal pathologies.
引用
- Wang N, Yao F, Xu W, et al. The Transcription Factor Islet-1 Regulates Diabetes-Induced Inner Blood-Retinal Barrier Disruption. Invest Ophthalmol Vis Sci. 2025. PMID: 41042023. doi:10.1167/iovs.66.13.8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。